The 'anti-hype' vaccine

After years under the radar, RNA vaccines are finally emerging as immunotherapies to combat pandemics and cancer. But as Laura DeFrancesco reports, clinical validation remains elusive.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature biotechnology 2017-03, Vol.35 (3), p.193-197
1. Verfasser:	DeFrancesco, Laura
Format:	Artikel
Sprache:	eng
Schlagworte:	631/1647/2300 631/61 631/61/51/2293 692/4028/67/1059/2325 Agriculture Antigens Bioinformatics Biomedical Engineering/Biotechnology Biomedicine Biotechnology California Cancer Cancer vaccines Care and treatment Epidemics Health aspects Immune response Immunotherapy Life Sciences news-feature Pandemics Pharmaceutical industry Product development Prostate cancer R&D Research & development Ribonucleic acid RNA Switzerland Trends Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	After years under the radar, RNA vaccines are finally emerging as immunotherapies to combat pandemics and cancer. But as Laura DeFrancesco reports, clinical validation remains elusive.
ISSN:	1087-0156 1546-1696
DOI:	10.1038/nbt.3812